TY  - GEN
AU  - Buckner,J C
AU  - Schomberg,P J
AU  - McGinnis,W L
AU  - Cascino,T L
AU  - Scheithauer,B W
AU  - O'Fallon,J R
AU  - Morton,R F
AU  - Kuross,S A
AU  - Mailliard,J A
AU  - Hatfield,A K
AU  - Cole,J T
AU  - Steen,P D
AU  - Bernath,A M
TI  - A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma
SN  - 0008-543X
PY  - 2001///0809
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Carmustine
KW  - Combined Modality Therapy
KW  - Disease Progression
KW  - Female
KW  - Glioma
KW  - Humans
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3
ER  -